How many insider declarations has Younis Husam filed?

Younis Husam has filed 1 public insider declaration with SEC (Form 4).

What is Younis Husam's role?

Younis Husam's reported role is not specified by the regulator across the filings.

Which companies does Younis Husam report trades for?

Younis Husam reports trades for Atrium Therapeutics, Inc..

← Executives ★ Sign in to follow

YH

Younis Husam

OFFICERM

·SEC (Form 4)

Atrium Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Younis Husam. Officer active across 1 company, notably Atrium Therapeutics, Inc.. In total, 1 disclosures have been published. Activity tracked since 20 April 2026. The latest transaction was disclosed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Younis Husam

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Atrium Therapeutics, Inc. (US)

申报1 总计

◆

Younis Husam

Chief Scientific Officer高管2026年4月20日Atrium Therapeutics, Inc.

0SEC ↗

30,000 股0Common StockSEC:0001193125-26-170906:0

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

YH

Younis Husam

OFFICERM

·SEC (Form 4)

Atrium Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Younis Husam. Officer active across 1 company, notably Atrium Therapeutics, Inc.. In total, 1 disclosures have been published. Activity tracked since 20 April 2026. The latest transaction was disclosed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.